Table 1.
Correlations Between ARFIP2 Expression and Clinicopathological Characteristics in 87 HCC Patients
| Clinicopathological Feature | ARFIP2 Expression | χ2 | P value | |
|---|---|---|---|---|
| High | Low | |||
| n=52 (60.47%) | n=34 (39.53%) | |||
| Gender (M/F) | 44/8 | 28/6 | ||
| Age (years) | 58.76 ± 3.12 | 55.46 ± 2.09 | 0.983 | 0.512 |
| AFP (ng/mL) | 3928± 2069 | 2107 ± 1086 | 2.545 | 0.078 |
| Tumor size (cm) | 9.72±1.36 | 7.55±1.21 | 0.177 | 0.053 |
| Tumor number | ||||
| Single | 7 (13.46%) | 22 (64.71%) | 0.532 | 0.031* |
| Multiple | 45 (86.54%) | 12 (35.29%) | ||
| Microvascular invasion | ||||
| Absent | 34 (65.38%) | 29 (85.29%) | 5.775 | 0.008** |
| Present | 18 (34.62%) | 5 (14.71%) | ||
| Tumor differentiation | ||||
| I–II | 5 (9.62%) | 8 (23.53%) | 6.08 | 0.036* |
| III–IV | 47 (90.38%) | 26 (76.47%) | ||
| TNM stage | ||||
| I–II | 23 (44.23%) | 23 (67.65) | 4.42 | 0.027* |
| III–IV | 29 (55.77%) | 11 (32.35) | ||
Notes: *P < 0.05; **P < 0.01.
Abbreviations: AFP, α-fetoprotein; TNM, Tumor Node Metastasis.